Maternal-fetal complications in pregnant women with systemic lupus erythematosus

Authors

Keywords:

lupus erythematosus systemic, maternal, fetal, complications

Abstract

Introduction: systemic lupus erythematosus is an autoimmune disease that mainly affects women of childbearing age and has been associated with increased maternal-fetal morbidity and mortality.
Objective: to describe the main maternal-fetal complications in pregnant women with systemic lupus erythematosus.
Methods: a developmental, descriptive and cross-sectional research was conducted in 137 pregnant women with a diagnosis of systemic lupus erythematosus attended at the “Mariana Grajales” and “Arnaldo Milián Castro” Hospitals between January 2015 and December 2019 with a predominance of documentary analysis.
Results: pregnant women between 20 and 24 years old, with medium-high school level, primigravidae, who attended five or more Prenatal Care Consultations and one or two Rheumatology and High Obstetric Risk Consultations during pregnancy predominated. The 94.98% were diagnosed before pregnancy and the interval of evolution was predominantly between one and four years. The main comorbidity was arterial hypertension (22.63%), followed by diabetes mellitus (18.25%). The most frequent maternal complications were preterm delivery (28.47%) and premature rupture of membranes (24.81%), while the most frequent fetal complications were prematurity (32.77%) and low birth weight (24.37%).
Conclusions: the study showed an increase in maternal-fetal complications in pregnant women with systemic lupus erythematosus.

Downloads

Download data is not yet available.

Author Biographies

Daisy Carballé García, Hospital Provincial Clínico Quirúrgico Universitario “Arnaldo Milián Castro”

Especialista de I Grado en Medicina General Integral. Especialista de I Grado en Reumatología. Profesora Instructora en la Unversidad de Ciencias Médicas de VIlla Clara.

Enrique Martínez González, Hospital Provincial Clínico Quirúrgico Universitario “Arnaldo Milián Castro”

Especialista de I Grado en Medicina General Integral. Esopecialista de I Grado en Reumatología. Profesor Asistente en la Unversidad de Ciencias Médicas de VIlla Clara.

Lisbet Mesa Fernández, Hospital Provincial Clínico Quirúrgico Universitario “Arnaldo Milián Castro”

Especialista de I Grado en Medicina General Integral. Especialista de I Grado en Reumatología. Profesor Asistente en la Unversidad de Ciencias Médicas de VIlla Clara.

René Espinosa Machado, Hospital Provincial Pediátrico Universitario “José Luis Miranda”

Especialista de I Grado Medicina General Integral. Especialista de I Grado en Neonatología. Profesor Asistente en la Unversidad de Ciencias Médicas de VIlla Clara.

Neila Teresa Pérez Carballé, Unversidad de Ciencias Médicas de VIlla Clara

Estudiante de Enfermería

María Gabriela Morales Nerey, Unversidad de Ciencias Médicas de VIlla Clara

Estudiante de Medicina

References

1.Mercado Crow MK. Etiología y patogenia del lupus eritematoso sistémico. En: Firestein GS, Budd RC, Gabriel SE, McInnes IB, O´Dell JR. Kelley y Firestein. Tratado de reumatología. 10ma ed. Barcelona: Elsevier; 2018. p. 1329-1344.

2.Bermúdez Marrero WM, Vizcaíno Luna Y, Bermúdez Marrero WA. Lupus eritematoso sistémico. Acta Méd Centro [Internet]. 2017 [citado 21/11/2022];11(1):82-95. Disponible en: http://www.revactamedicacentro.sld.cu/index.php/amc/article/view/795/980

3.Dall’Era M, Wofsy D. Manifestaciones clínicas del lupus eritematoso sistémico. En: Firestein GS, Budd RC, Gabriel SE, McInnes IB, O´Dell JR. Kelley y Firestein. Tratado de reumatología. 10ma ed. Barcelona: Elsevier; 2018. p. 1345-1367.

4.Nares Torices MA, Hernández Pacheco JA, Estrada Altamirano A, Mendoza-Calderón A, Cervera-Buenfil CI, Villalva-Hernández LD, et al. Lupus eritematoso sistémico activo durante el embarazo. Curso clínico y pronóstico en una Unidad de Cuidados Intensivos. Perinatol Reprod Hum [Internet]. 2012 [citado 21/11/2022];26(2):96-105. Disponible en: https://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0187-53372012000200004

5.Bundhun PK, Soogund MZ, Huang F. Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: a meta-analysis of studies published between years 2001-2016. J Autoimmun [Internet]. 2017 [citado 21/11/2022];79:17-27. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28256367/. https://doi.org/10.1016/j.jaut.2017.02.009

6.García Posada R, Ospina AT. Lupus eritematoso sistémico y embarazo: una visión desde la medicina materno fetal. XXVI Curso de Actualización en Ginecología y Obstetricia [Internet]. 2018 [citado 21/11/2022];26:13-20. Disponible en: https://revistas.udea.edu.co/index.php/ginecologia_y_obstetricia/article/view/346809

7.Sociedad Española de Reumatología. Manual SER de enfermedades reumáticas. 6ta Ed. Barcelona: Elsevier España; 2014. p. 335-347.

8.Rivas-López R, García Figueroa RB, Romero Cabello R. Lupus eritematoso sistémico y embarazo. Ginecol Obstet Mex [Internet]. 2003 [citado 21/11/2022];71(8):400-408. Disponible en: https://www.imbiomed.com.mx/articulo.php?id=24482

9.Ocampo Ramirez SM, Hoyos Patiño S, Lambertino Montaño JR, Gutiérrez-Marín JH, Campo-Campo MN, Sanín-Blair JE. Caracterización de mujeres embarazadas con lupus eritematoso sistémico y resultados materno-fetales en el noroeste de Colombia. Estudio descriptivo. Iatreia [Internet]. 2019 [citado 21/11/2022];32(4):266-275. Disponible en: http://www.scielo.org.co/pdf/iat/v32n4/0121-0793-iat-32-04-00266.pdf

10.Stuht López D, Santoyo Haro S, Lara Barragán I. Lupus eritematoso sistémico en el embarazo. Acta Méd Grupo Ángeles [Internet]. 2018 [citado 21/11/2022];16(4):331-338. Disponible en: https://www.scielo.org.mx/pdf/amga/v16n4/1870-7203-amga-16-04-331.pdf

11.Doria A, Iaccarino L, Arienti S, Ghirardello A, Zampieri S, Rampudda ME, et al. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol [Internet]. 2006 [citado 21/11/2022];22(2):234-241.Disponible en: https://pubmed.ncbi.nlm.nih.gov/16704920/. https://doi.org/10.1016/j.reprotox.2006.04.001

12.Vilardell Tarrés M, Ordi Ros J. Lupus eritematoso sistémico. En: Rozman BorstnarC, Cardellach López F. Farreras-Rozman Medicina Interna. 17a ed. Barcelona: Elsevier; 2012. p. 1017-1022.

13.Espinosa G, Galindo Izquierdo M, Marcos Puig B, Casellas Caro M, Delgado Beltrán P, Martínez López JA, et al. Control del embarazo en pacientes con lupus eritematoso sistémico y síndrome antifosfolípido. Parte 1: Infertilidad, preservación ovárica y valoración preconcepcional. Documento de consenso de la Sociedad Española de Ginecología y Obstetricia (SEGO), Sociedad Española de Medicina Interna (SEMI) y Sociedad Española de Reumatología (SER). Reumatol Clin [Internet]. 2021 [citado 21/11/2022];17(2):61-66. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1699258X19301305. https://doi.org/10.1016/j.reuma.2019.09.002

14.Clowse ME, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol [Internet]. 2008 [citado 21/11/2022];199(2):127.e1–127.e6. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2542836/. https://doi.org/10.1016/j.ajog.2008.03.012

15.Larburu Zavala S. Influencia mutua entre lupus eritematoso sistémico y embarazo [tesis]. Leioa: Universidad del País Vasco; 2017 [citado 21/11/2022]. Disponible en: https://addi.ehu.es/bitstream/handle/10810/31041/TFG_Larburu_Zavala_Rev.pdf

16.Mesa Abad P, Tovar Muñoz L, Serrano Navarro I, Ventura Puertos P. Berlango Jiménez J. El embarazo en mujeres con lupus eritematoso sistémico: una revisión integrativa. Enferm Nefrol [Internet]. 2020 [citado 21/11/2022];23(1):11-21. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2254-28842020000100002. https://dx.doi.org/10.37551/s2254-28842020002

17.González Arenas E, Aceves Barrios CA, Reyes Gómez U, Yalaupari Mejía JP. Endocarditis infecciosa asociada a cables de marcapaso en lactante menor con lupus neonatal. Enf Infec Microbiol [Internet]. 2022 [citado 21/11/2022];42(2):82-90.Disponible en: https://www.medigraphic.com/pdfs/micro/ei-2022/ei222g.pdf

Downloads

Published

2023-04-28

How to Cite

1.
Carballé García D, Martínez González E, Mesa Fernández L, Espinosa Machado R, Pérez Carballé NT, Morales Nerey MG. Maternal-fetal complications in pregnant women with systemic lupus erythematosus. Acta Méd Centro [Internet]. 2023 Apr. 28 [cited 2025 Jun. 27];17(2):301-9. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/1780

Issue

Vol. 17 No. 2 (2023): Abril-Junio

Section

Original Articles

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).